Perfil neuropsicológico de paciente adulto joven con síndrome Z / Neuropsychological profile of young adult patient with Z syndrome

Esta investigación tiene como objetivo establecer el perfil neuropsicológico de una paciente quien padece Síndrome de apnea obstructiva junto con Síndrome metabólico, esta interacción la cual actualmente se conoce como Síndrome Z. Mediante un estudio descriptivo de caso único, teniendo en cuenta una batería neuropsicológica previamente determinada, se caracteriza el desempeño cognitivo de un paciente masculino de 34 años con el diagnóstico mencionado. Los datos fueron analizados con la baremación correspondiente a cada prueba, encontrando dificultades cognitivas a nivel de función ejecutiva, especialmente en funciones de la corteza prefrontal dorsolateral. Como conclusión se establece que el síndrome Z se asocia a un trastorno neurocognitivo menor en un adulto joven.

This research aims to establish the neuropsychological profile of a patient suffering from obstructive apnea syndrome along with metabolic syndrome, this interaction is currently known as Z Syndrome. A descriptive study of a single case, considering a neuropsychological battery previously determined, the cognitive performance of a 34-year-old male patient with the mentioned diagnosis is characterized. The data was analyzed with the corresponding standard to each test, finding cognitive difficulties at the level of executive function, especially in functions of the dorsolateral prefrontal cortex. In conclusion, it is established that Z syndrome is associated with a minor neurocognitive disorder in a young adult.

Incidence, indications, and outcomes of Yag Capsulotomy in eyes Implanted with an accommodating intraocular lens

Objectives@#To do report the incidence of capsular changes in Crystalens-implanted eyes and analyze the indications and outcomes of yag capsulotomy. @*Methods@#We reviewed the records of 411 eyes of 258 patients implanted with the Crystalens IOL. Capsular change indications for yag capsulotomy were posterior capsular opacification (PCO), lens tilt, and capsular striae. Eyes in each indication were further subdivided into therapeutic yag (TY) and prophylactic yag (PY) groups. Outcomes before and after yag capsulotomy were analyzed. @*Results@#Ninety of 411 crystalens-implanted eyes (22%) had undergone yag capsulotomy. Sixty-one eyes had PCO, 12 had lens tilt, and 17 had striae. Twenty-seven eyes belonged to the therapeutic (TY) and 63 eyes to the prophylactic (PY) yag subgroups. The mean interval between phacoemulsification and yag capsulotomy was 10 months. In the TY PCO subgroup, uncorrected distance visual acuity (UDVA) changed from 20/40 pre-yag to 20/25 post-yag, uncorrected near visual acuity (UNVA) from J3 to J2, manifest refraction spherical equivalent (MRSE) from -0.43D to -0.2D. In the TY tilt subgroup, UDVA changed from 20/50 to 20/30, UNVA was unchanged at J2, and MRSE from -1.21D to -0.89D. In the TY striae group, UDVA changed from 20/50 to 20/30, UNVA from J3 to J2, and MRSE from 0.62D to -0.4D. In the PY PCO subgroup, UDVA was unchanged at 20/25, UNVA unchanged at J2, and MRSE changed from -0.52D to -0.47D. In the PY tilt subgroup, UDVA changed from 20/25 to 20/20, UNVA unchanged at J2, and MRSE changed from -0.87D to -0.45D. In the PY striae subgroup, UDVA was unchanged at 20/30, UNVA changed from J3 to J2, and MRSE changed from -0.62D to -0.7D. @*Conclusion@#Capsular changes occurred after Crystalens implantation that necessitated yag capsulotomy. Once vision has deteriorated, a therapeutic yag treatment can help improve vision. If capsular changes have occurred but vision has not deteriorated, a prophylactic yag capsulotomy can stabilize visual and refractive outcomes.

Clinical comparison of visual and refractive outcomes of two models of accommodative intraocular lenses

Objective@#To evaluate the visual and refractive outcomes of eyes implanted with the Crystalens HD and the Crystalens AO intraocular lens.@*Methods@#We retrospectively reviewed the records of 159 eyes of 100 patients implanted with the Crystalens HD IOL and 108 eyes of 66 patients implanted with the Crystalens AO IOL. Visual and refractive outcomes preoperatively and postoperatively were assessed and compared between the lenses. @*Results@#At 1 year, uncorrected distance VA was 20/30 in 78% of eyes in the HD and 76% of eyes in the AO groups. Uncorrected intermediate VA was 20/30 in 90% of eyes in both groups. Uncorrected near VA was J3 in 92% in the HD and 90% in the AO groups. Comparing the two groups, the difference in uncorrected distance (p=0.60), intermediate (p=0.77), and near (p=0.64) vision was not statistically significant. Spherical equivalent was -0.42D +/-0.51D in the HD and -0.6 +/-0.48D in the AO groups (p=0.10). @*Conclusion@#Refractive outcomes were similar between the Crystalens HD and AO groups. Mild myopic refractive outcomes were targeted and achieved in both lens groups. These refractive outcomes provided good uncorrected distance, intermediate, and near vision postoperatively.